Search results: IDE
Product group Proteins / Signaling Molecules
Human recombinant Insulysin/IDE proteinPROTP14735-1
ApplicationsFunctional Assay, Other Application
Protein IDP14735
- SizePrice
Product group Proteins / Signaling Molecules
Human recombinant Insulysin/IDE proteinPROTP14735-1
ApplicationsFunctional Assay, Other Application
Protein IDP14735
- SizePrice
Product group Proteins / Signaling Molecules
Human recombinant Insulysin/IDE proteinPROTP14735-1
ApplicationsFunctional Assay, Other Application
Protein IDP14735
- SizePrice
Product group Antibodies

Anti-CD154 [IDEC-131 (Toralizumab)]AB01678-1.1-BT
ApplicationsImmunoFluorescence, Neutralisation/Blocking
TargetCD40LG
- SizePrice
Product group Antibodies

Anti-CD154 [IDEC-131 (Toralizumab)]Ab01678-1.1
ApplicationsImmunoFluorescence, Neutralisation/Blocking
TargetCD40LG
- SizePrice
Product group Antibodies

Anti-CD154 [IDEC-131 (Toralizumab)]AB01678-10.0-BT
ApplicationsImmunoFluorescence, Neutralisation/Blocking
TargetCD40LG
- SizePrice
Product group Antibodies

Anti-CD154 [IDEC-131 (Toralizumab)]Ab01678-10.0
ApplicationsImmunoFluorescence, Neutralisation/Blocking
TargetCD40LG
- SizePrice
Product group Antibodies

Anti-CD154 [IDEC-131 (Toralizumab)]AB01678-10.3-BT
ApplicationsImmunoFluorescence, Neutralisation/Blocking
TargetCD40LG
- SizePrice
Product group Antibodies

Anti-CD154 [IDEC-131 (Toralizumab)]Ab01678-10.3
ApplicationsImmunoFluorescence, Neutralisation/Blocking
TargetCD40LG
- SizePrice
Product group Antibodies

Anti-CD154 [IDEC-131 (Toralizumab)]AB01678-23.0-BT
ApplicationsImmunoFluorescence, Neutralisation/Blocking
TargetCD40LG
- SizePrice
Product group Antibodies

Anti-CD154 [IDEC-131 (Toralizumab)]Ab01678-23.0
ApplicationsImmunoFluorescence, Neutralisation/Blocking
TargetCD40LG
- SizePrice
Product group Antibodies

Anti-CD154 [IDEC-131 (Toralizumab)]AB01678-3.0-BT
ApplicationsImmunoFluorescence, Neutralisation/Blocking
TargetCD40LG
- SizePrice
Didn't find what you were looking for?
Search through our product groups to find the right product
Back to overview